凱中精密(002823.SZ):控股股東、實控人及一致行動人再減持凱中轉債41.6萬張
格隆匯12月27日丨凱中精密(002823.SZ)公佈,2019年12月27日,公司接到控股股東、實際控制人及其一致行動人通知,自2019年3月18日-12月27日期間,吳瑛通過深交所交易系統出售其所持有的凱中轉債合計19.4萬張,佔發行總量的4.66%;張浩宇通過深交所交易系統出售其所持有的凱中轉債合計18.1885萬張,佔發行總量的4.37%;深圳凱合投資合夥企業(有限合夥)通過深交所交易系統出售其所持有的凱中轉債合計4.011萬張,佔發行總量的0.96%。此次出售後,公司控股股東、實際控制人及其一致行動人現仍合計持有凱中轉債56.8005萬張,佔發行總量的13.65%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.